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Abstract
With the evolution of cancer care and chemotherapy agents over the last 15 years there has
been an evident shift in care from the inpatient to the ambulatory setting. There is a
growing need for cancer care, particularly in the ambulatory (outpatient) setting. Patients
receiving chemotherapy in the outpatient setting return home immediately after completing
treatment and do not have direct medical and nursing supervision to monitor for and
address side effects or adverse reactions of treatment in a hospital inpatient setting. Nurse
telephone follow-up post initial chemotherapy allows for assessment and timely
management of potential side effects experienced after the administration of chemotherapy
in the outpatient setting. The purpose of this quality improvement project was to develop a
standardized nurse telephone follow-up procedure post initial chemotherapy. The author
developed an electronic script guideline and documentation tool along with a process for
conducting the nurse-initiated calls. The project design included an educational activity
and a post evaluation of the telephone follow-up procedure. Fifteen
biotherapy/chemotherapy nurses participated in a four week pilot. During the four week
pilot period 14 out of 34 first time chemotherapy patients received telephone follow-up
utilizing the script guidelines. Ten nurses (N=10, 67%) completed the post evaluation
survey. Results indicated that overall the script guidelines for telephone follow-up post
initial chemotherapy was well received by staff and utilized appropriately. Replication of
this project should include examining the impact of telephone follow-up on patient
satisfaction and outcomes. The APRN is essential in promoting evidence-based practice
and bringing it into the daily practices of staff nurses to improve the quality of care for
patients and their families.
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NURSE TELEPHONE FOLLOW-UP POST INITIAL CHEMOTHERAPY: A
QUALITY IMPROVEMENT PROJECT

Background/Statement of the Problem
In the constantly changing world of cancer care, it is important to recognize the
shift in care from inpatient to the ambulatory setting as part of the national progression
within healthcare delivery. There is also increased demand for cancer care, influenced in
part by the increase in newly insured patients. Millions of uninsured signed up for health
insurance last year because of the Affordable Care Act insurance mandate. Included in
the pool of newly insured people are cancer patients and survivors who had previously
struggled to find adequate, affordable coverage because of their history of cancer. Also
contributing to the demand for cancer care is the burden of the aging population,
associated with increased number of cancer cases and cancer remaining the leading cause
of death (American Society of Clinical Oncology, 2015). Finally, the cancer survival
rate for five years is increasing, and so then are the number of cancer survivors increasing
demand for cancer care (National Cancer Institute, 2015). The growing number of cancer
survivors will require long-term follow-up and monitoring to detect and treat recurrence
or new cancers and manage long-term treatment side effects.
The American Cancer Society (2015) estimates that 1,658,370 new cases of
cancer will be diagnosed in 2015, which is down approximately 7,000 cases from 2014.
Despite the decrease in the number of new cases, there is a growing population of first
time oncology patients receiving initial chemotherapy in the outpatient setting (American
Society of Clinical Oncology), magnifying the need for improved nurse to patient
communication after first (initial) chemotherapy treatment. Patients receiving
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chemotherapy in the outpatient clinic setting return home immediately after completing
treatment and do not have direct medical and nursing supervision to monitor for and
address side effects or adverse reactions of treatment. Patients may even return home
with chemotherapy infusing for 48-72 hours with a home infusion pump. The initiation of
chemotherapy is an extremely anxiety provoking experience for many patients and their
families, whether inpatient or outpatient. Patients’ primary concern is what to expect
during and immediately following treatment. Patients are at an increased risk of
developing and experiencing symptoms while at home that require medical care
(emergency department or admission). These symptoms can include pain, dyspnea,
nausea, vomiting, diarrhea, constipation and mucositis (Mooney, 2002). Patients
experiencing the side effects of treatment at home, as opposed to inpatient, need adequate
resources and guidance to avoid hospital admissions or visits to the emergency
department (Mooney). In addition to the acute symptoms patients face, long-term
problems accompany cancer treatment such as depression, anxiety, fear of recurrence,
loneliness, body image changes, and effects on family relationships, social environment
and finances (Mooney). Chemotherapy-related symptoms disrupt normal daily living
activities and diminish quality of life (Hassett, 2011). Open communication between the
nurse and patient will contribute to coordinated and comprehensive patient-centered care.
Chemotherapy administration in the ambulatory setting is seen as economical and
preferable for most patients (Mooney, 2002). The United States Food and Drug
Administration (FDA) approved 18 new cancer treatment drugs and biologics in 2013 to
bring the total number of FDA-approved anticancer drugs to more than 170 (American
Society of Clinical Oncology, 2015). The availability of safer and better treatments,
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along with an expanded focus on value and quality of cancer care, has contributed to
increasing survival rates and improved quality of life for patients living with cancer
(American Society of Clinical Oncology, 2015). Targeted therapies work at the
molecular level and are tailored to each cancer, leading to the ability to target serious and
life threatening conditions (Gerber, 2008).
The most frequent reason a patient calls a cancer clinic is to report symptoms or
clarify questions about plan of care or treatment (Flannery, 2009). After returning home
from the clinic, many patients and family members find themselves struggling to
remember all the information reviewed throughout the treatment process along with
symptoms to monitor. Many patients are unable to adequately manage side effects at
home and do not seek effective follow-up care. Cancer patients receiving chemotherapy
require accurate and reliable information in order to adequately perform self-care and
cope with the side effects of treatment (Flannery). Ensuring that the patient or their
family is contacted 24-48 hours after initiation of chemotherapy may alleviate anxiety,
knowledge deficit and provide prompt follow-up of symptoms and concerns along with
reinforcement of the care plan.
Post chemotherapy telephone follow up by the nurse allows for open
communication and provides reassurance to the patient related to their cancer care (Cox,
2003). A primary benefit of telephone follow-up is the ability to assess patients in a
timely manner for potential complications that require further evaluation or hospital
admission (Lynch, 2010). The nursing assessment and collaboration with MD will allow
for timely management of symptoms and the potential to decrease hospital admission or
emergency department visits. Along with increased communication, concise
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documentation of nurse communication post initial chemotherapy is essential to
providing quality cancer care (Lynch, 2010). Documentation in the patient record allows
all members of the patient’s care team to be aware of any interventions or education that
was provided during the telephone follow-up. Continuity of care is desired in all settings,
particularly in ambulatory, where there is a strong potential for fragmented care
(American Society of Clinical Oncology, 2015).
Telephone follow-up can be essential to timely management of chemotherapy side
effects; however it must be completed using a standardized process. Currently patients
and their families are instructed to call the clinic if they have any questions or concerns
following chemotherapy administration. Instructing the patient to call with any questions
or concerns can lead to the potential for missed follow-up due to an increased number of
incoming calls. Taking a proactive approach would decrease the number of incoming
calls to the clinic and allow for prompt follow-up with the patient. In the cancer center at
Rhode Island Hospital there is no protocol or process in place for nurse telephone followup after the initiation of chemotherapy. The purpose of this quality improvement project
is to develop and pilot a nurse telephone follow-up procedure post initial chemotherapy.
A review of relevant literature will be presented next.
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Literature Review
A literature review was performed using the CINAHL, UpToDate, and Pub Med
databases and using keywords cancer care, chemotherapy, follow-up, side effects,
adverse events, and telephone follow-up. The search was limited to materials in English
from 1999- present.
Epidemiology of Cancer Care
In 2014, significant progress was made in improving the quality of cancer care as
demonstrated by growth in the number of new drugs and technologies approved by the
Food and Drug Administration, improvements in the five-year cancer survival rates for
many cancer types, and the increasing number of cancer survivors. According to the
American Cancer Society, the five year survival rate increased from 55% in 1987-1989 to
68% in 2004-2010 (2015). However, by 2030 the number of new cancer cases in the
United States will increase by 45%, from 1.6 million to 2.3 million cases annually
(American Society of Clinical Oncology, 2015). Along with the increase in cancer cases
comes a need for improved quality of cancer care. The course of disease in patients has
become increasingly unpredictable, resulting in equally unpredictable adverse events,
which often lead to unscheduled hospitalizations (Coriat, 2012). An integrative approach
is required to address the unpredictability identified in cancer care that involves a
multidisciplinary approach and consistent follow-up. The administration of ambulatory
chemotherapy means that patients will not be under the care of a healthcare provider
when they are most likely to experience side effects.
Chemotherapy: Targeted vs. Traditional
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Chemotherapy is a systemic therapy as drugs are distributed throughout the body
by the bloodstream and be limited by the toxic effects on normal tissue (Polovich, 2014).
Chemotherapy works by stopping or slowing the growth of cancer cells, which grow and
divide quickly (Polovich). The array of cancer treatments available continues to grow
with time and further developments in the field. Traditional cytotoxic chemotherapy
targets rapidly dividing cells including cancer cells and certain normal tissues (Gerber,
2008). Cytotoxic chemotherapy works primarily through the inhibition of cell division
and in addition to cancer cells, other rapidly dividing cells (e.g., hair, gastrointestinal
epithelium, bone marrow) are affected by these drugs (Gerber). Traditional cytotoxic
chemotherapy remains the treatment of choice for many malignancies; however targeted
therapies are now a component of treatment for many types of cancer.
Targeted therapies are currently the focus of much anticancer drug development.
Targeted therapies are drugs or other substances that block the growth and spread of
cancer by interfering with specific molecules that are involved in the growth, progression,
and spread of cancer (National Cancer Institute, 2015). The use of targeted therapies
grew from 11% in 2003 to 46% in 2013 (American Society of Clinical Oncology, 2015).
Targeted therapies differ from standard chemotherapy in a number of ways
•Targeted therapies act on specific molecular targets that are associated with cancer,
whereas most standard chemotherapies act on all rapidly dividing normal and cancerous
cells.
•Targeted therapies are deliberately chosen or designed to interact with their target,
whereas many standard chemotherapies were identified because they kill cells.
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•Finally targeted therapies are often cytostatic (that is, they block tumor cell
proliferation), whereas standard chemotherapy agents are cytotoxic (that is, they kill
tumor cells) (National Cancer Institute, 2015).
Despite advanced in chemotherapy, all therapies have significant and potentially
serious side-effects.
Chemotherapy: Side Effects
General. Symptoms that patients experience often are congruent with the type of
treatment received and vary through the course of treatment. It is a continuous challenge
for healthcare professionals to enhance the patient’s ability to cope with side effects
during treatment. Knowledge of common symptoms enables the nurse to provide the
patient with a predictable symptom profile, which represents a range of normal
experiences during and after cancer treatment (Pedersen, 2012). Patient information
needs to be tailored according to the patient’s background, prior understanding, and level
of anxiety (Pedersen). It has also been identified that due to an increase in the number of
outpatients and demand for efficiency, patients experience a lack of access to healthcare
providers, communication difficulties and information overload (Pedersen).
Henry, Viswanathan, Elkin, Traina, Wade, and Cella (2008) conducted a crosssectional survey to examine the prevalence of chemotherapy associated side effects and
related treatment burden. Identifying and treating the side effects associated with cancer
treatment can reduce their negative impact on patients’ daily lives and health-related
quality of life. The survey conducted by phone or completed online assessed fatigue,
anxiety, depression, pain, alopecia, nausea, vomiting and additional symptoms. A total of
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814 patients reported receiving chemotherapy at the time of survey and were included in
the results of the survey. The majority of patients, 88%, reported at least one side effect
of their treatment. Fatigue (80%), pain (48%), nausea and/or vomiting (48%), anxiety
(46%), and insomnia (45%) were the most common side effects reported (Henry). The
high prevalence of chemotherapy associated side effects identified in the survey
underlines the need for improvement assessment and management of said side effects.
Hassett, Rao, Brozovic, Stahl, Schwartz, Maloney, and Jacobson (2011) found
that gastrointestinal problems, such as nausea, vomiting, or diarrhea, were responsible for
the largest percentage of chemotherapy related hospitalizations followed by infectious
problems such as pneumonia or febrile neutropenia. Among the 2,068 cancer patients
identified in the prospective cohort study, 826 total hospitalizations were identified
between January 2003 and December 2006. Of the identified hospitalizations, 262
(26.3%) were classified as chemotherapy related. It was found that there were five
chemotherapy related hospitalizations on average per month. Two thirds of
chemotherapy related hospitalizations occurred during the first two cycles of
chemotherapy; only 8% occurred after the fourth cycle. Chemotherapy related side
effects and toxicities must be assessed as part of routine clinical practice particularly
during the beginning cycles of chemotherapy to properly manage potential adverse
effects.
Targeted Chemotherapy. The proper management of targeted chemotherapy
side effects can lead to decreased risk of dose reduction, dose delay, or termination of
therapy (McIntyre, 2015). Patient education is essential and patients need to be alerted
about what to expect during treatment including nursing education regarding the patients
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of treating side effects early, rather than waiting until they become more severe
(McIntyre). Despite the high selectivity of targeted therapies, a range of previously
unknown and sometimes unpredictable side effects can emerge (Widakowich, 2007).
Majority of side effects are directly related to the specific molecular target in normal
tissues inhibited or modulated by the specific drug. Cutaneous toxicity is seen with the
inhibitors of epidermal growth factor receptor (EGFR) and the most commonly observed
side effect is an acneiform rash (Widakowich). The acneiform rash is characterized by
erythematous follicular papules and pustules that appear in areas rich in sebaceous
glands. Usually, the acneiform rash appears a few days after the start of anti-EGFR
treatment and is more intense at weeks 2 or 3 of treatment (Widakowich).
Gastrointestinal toxicity with anti-EGFR therapies presents as post-chemotherapy
diarrhea and can also be a dose-limiting toxicity for most small molecule EGFR
(Widakowich).
Adverse Event Reporting. Adverse event reporting in oncology is inherently
complex. An adverse event as defined by the National Cancer Institute (2015) is any
untoward medical occurrence associated with the use of a drug, whether or not
considered drug related (abnormal lab finding, symptom, or disease) The National Cancer
Institute’s Common Terminology Criteria for Adverse Events (CTCAE) is the standard
approach for documenting adverse events in cancer clinical trials (Trotti, 2007).
Common Terminology Criteria for Adverse Events is designed as an instrument to be
used to document adverse events identified through a combination of clinical and
laboratory evaluation. The system is also used in the clinical setting to support treatment
decisions, symptom management and medication administration. Clinician capture of
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subjective data requires first patient report of the symptom then the clinician making an
assessment and interpreting the symptom (Badalucco, 2011). Common Terminology
Criteria for Adverse Events tools have not been through a formal development or
validation process; however some content validity is conferred through 30 years of
widespread use and iterative improvements (Trotti, 2007).
Use of Telephone Contact for Follow-Up and Symptom Management
Patient Calls to Oncology Clinic. Lucia, Decker, Israel, and Decker (2007)
studied the number, volume, and treatment characteristics of all patient related telephone
calls to a cancer nurse at a community oncology practice during a one week period.
There were a total of 332 patient calls reviewed with 30% of calls pertaining to
prescriptions and 20% to symptom management (Lucia et al.). Lucia et al. found that for
87% of the calls the triage nurse was able to assist the caller without any further
intervention. The utilization of oncology nurses for telephone triage in the ambulatory
oncology setting demonstrates the effectiveness of resolving patient issues thereby
reducing the cost of care for patients related to unnecessary emergency department visits
or hospitalizations (Lucia et al.).
In a descriptive retrospective study conducted by Flannery, Phillips, and Lyons
(2009), the telephone calls to medical oncology and hematology were analyzed. A
telephone call record instrument was used to analyze data along with a demographic and
medical data instrument. Flannery et al. identified 5, 283 telephone calls, involving 1,486
individuals, were placed or received in a four month time period. It was found that the
most frequent reasons for calling were to request diagnostic or blood work results, report
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symptoms, and to clarify questions about plan of care or treatment. The top three patient
populations identified by number of calls were hematology, breast cancer, and
gastrointestinal cancer. The data gathered demonstrates that telephone calls are a large
component of ambulatory oncology practice.
Nurse-initiated Telephone Follow-up; Non-Oncology Population. Nesari,
Zakerimoghadam, Rajab, Bassampour, and Faghihzadeh (2010) examined the effect of
telephone follow-up on adherence to a diabetes therapeutic regimen. Random sampling,
along with screening, was utilized to obtain a sample size of 60 patients with a diagnosis
of type 2 diabetes who attended the Iranian Diabetes Society. The study was conducted
over a three month period using a data sheet to record hemoglobin A1C level and a selfreported questionnaire. Study participants attended a three day diabetes self-care
education program where upon completion there were randomly assigned to the
experimental or control group. The experimental group received telephone follow-up
from a master’s nursing degree student for 12 weeks, twice per week for the first month
and then weekly for the second and third months. During each telephone call, health
behaviors, including diet, exercise, medication-taking, foot care, and regular monitoring
of blood glucose were assessed, education reinforced, and the participants questions
answered. It was found that the experimental group, after 12 weeks of telephone followup, had significantly higher diet, exercise, foot care, and blood glucose monitoring
adherence compared to the control group. The experimental group (n=30) reported 73%
adherence to diet compared to 64% in the control group. Exercise adherence was
significantly higher in the experimental group, 56%, versus the control group at 22%.
The experimental group reported 89% medication adherence while the control group
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reported 78%. Nesari et al. identified that telephone follow-up by a nurse improved the
level of glycemic control.
Burch (2012) reviewed the benefits of nurse-led telephone follow-up after major
colorectal surgery. The aim was to ensure a safe transition from hospital to home and
additionally to examine how patients recover at home. Telephone calls were made by the
enhanced recovery nurse within four weeks of surgery, with an ideal timing of two weeks
following discharge home from the hospital. The telephone follow-up was conducted
using a standardized document that included questions on diet, mobility, pain, wound
healing, and bowel and stoma function. Two hundred patients were contacted by
telephone in the 10 month period following discharge home. Of the 200 patients, 75%
(n=150) were contacted within the first two weeks. Intervention needed as a result of
making the call was only monitored for the latter 100 patients and led to difficulty in
assessing whether a problem had been prevented by making the telephone call. Of the
100 patients with intervention tracked, 76% of the calls were for advice or suggestion and
27% were to arrange medical clinic follow-up. Ninety-four patients expressed 102
concerns including wounds (8%), bowels (11%), stoma-related topics (5%), lack of
energy (3%), and pain (3%). Patients found telephone follow-up suitable to meet the
needs with advice giving for symptom management and providing reassurance on issues
of concern.
Stolic, Mitchell, and Wollin (2010) conducted a literature review of nurse-led
telephone interventions for people with cardiac disease. Inclusion criteria for literature
included telephone intervention, people with cardiac disease, post discharge period, nurse
delivered and published 1980-2009. Twenty-four articles met the inclusion criteria and
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were further reviewed. Of the twenty four studies reviewed, fifteen had at least one
positive finding. Positive effects were reported for seven studies in all outcome measures
including hospital readmission and mortality, attendance to cardiac rehabilitation
program, risk factor behaviors, and quality of life (Stolic). Mixed results with both
positive findings and no statistically differences detected were reported with eight
studies. Positive findings for risk factors, quality of life, psychological status, selfefficacy, and resource use were reported in the mixed studies (Stolic). Nine studies
reported no differences detected in any outcome measure including risk factors,
attendance to cardiac rehabilitation program, quality of life, psychological status, post
discharge complication, and satisfaction (Stolic). In the nine studies with no differences
detected similarities such as study rigor or sub optimal design, non-expert nurse
providing intervention and a fewer number of phone calls were identified. Nurse-led
telephone intervention may help people with cardiac disease for a variety of outcomes
including reducing risk factor behaviors, improving physical functioning, improving
psychological status, reducing hospital consumption and postoperative complications
(Stolic).
Nurse-initiated Telephone Follow-Up: Oncology
In a study by Kelly, Faught, and Holmes (1999), telephone follow-up was examined
in the setting of ovarian cancer treatment with the objective to assess the impact and any
benefit received from telephone follow-up between chemotherapy treatments.

The

gynecology oncology liaison nurse-initiated telephone follow-up five to seven days after
the patient received treatment. The study was conducted in a one year period with 31
patients responding to the questionnaire assessing the impact of telephone follow-up
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between chemotherapy treatments. The liaison nurse would make appropriate referrals to
other members of the patient’s care team if assessment demonstrated further needs and
guidance. A standardized assessment tool was used for documentation of the follow-up
call that included gastrointestinal symptoms, activity, elimination, and neurotoxicity. By
telephoning patients five to seven days after they had received chemotherapy, nurses were
able to aide patients in management of symptoms, assessment of side effects, and
promotion of self-care. Patients received a call-back study questionnaire to provide
feedback regarding benefits and perception of care. It was found that 87% of the 31
patients viewed telephone follow-up post chemotherapy as helpful.

With regard to

issues/concerns being addressed during the telephone call, 80% responded that their issues
had been addressed appropriately. According to the study findings, telephone follow-up
post chemotherapy made a positive impact on the patient’s perception of their care.
In a prospective and descriptive pilot study, Mooney, Beck, Friedman, and
Farzanfar (2002) examined telephone-linked care (TLC). Telephone-linked care is a
computer-based telecommunications system developed to help clinicians care for patients
with chronic health conditions. The system was used to monitor symptoms of patients that
had received chemotherapy. Patients would call into the system and report symptom
experiences through an automated system that would then alert the healthcare team by fax
of symptoms exceeding a specified threshold of severity. Patients were instructed to call
the system beginning 24 hours after chemotherapy and continue daily until their next
treatment cycle. A total of 27 patients were enrolled into the study. It was found that 67%
(n=27) of patients experienced symptoms severe enough to generate an alert, highlighting
the need for improved communication methods. An adherence rate was computed for each
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participant based on the number of times the participant actually called divided by the
number of anticipated calls (based on length of chemotherapy cycle) and a mean adherence
rate of 75% was found. Patients often did not take the initiative to call their providers even
when symptoms are of moderate or greater severity or when they are causing the patient
significant distress. Only two patients reported calling their nurse or physician to ask for
assistance with severe symptoms. Patients were instructed to call their provider to seek
symptom control even when reporting to the TLC system; the system was not to be seen
as a substitute for direct communication with provider (Mooney)
Cox and Wilson (2003) conducted a literature review on nurse led follow-up for
patients who have completed treatment, with a particular focus on telephone interventions.
Thirty-seven papers were reviewed relating to follow-up services for patients with cancer.
Many studies examined the appropriateness and effectiveness of follow-up upon
completion of cancer treatment.

Surveillance could be better served by a general

practitioner or a nurse in the terms of physical, social, and psychological rehabilitation
(Cox). Cox et al. identified that nurse-led intervention was effective in managing symptoms
along with greater satisfaction than conventional care and a decrease in costs by 31%.
Telephone follow-up was seen as a cost-effective method of communicating with patients
as part of their follow-up care and has consistently been shown to be a feasible and effective
way of improving support and symptom management post chemotherapy. Intervention by
telephone allowed for early identification of problems before they progress to crises, in
turn reducing the number of admissions and helping to redirect patients to the most suitable
resources (Cox).
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Providing prompt recognition and treatment of toxicity related to chemotherapy is
essential to optimal outcomes (Lynch, 2010). Optimal outcomes can be achieved by
prevention and early detection of toxicities that lead to improved treatment adherence,
decreased costs, and overall improved treatment outcomes. Telephone follow-up is an
efficient means to providing a patient and their family with optimal care during treatment.
In a quality improvement project conducted in an urban community cancer center in
Pennsylvania addressing follow-up in the older adults, patient’s side effects could be
treated via phone or an urgent office visit, not hospitalization. The telephone follow-up
calls were completed by the chemotherapy nurse or geriatric social worker with the purpose
of improving care for the older adult receiving chemotherapy. Patients were called every
other day for a total of five calls and a standard documentation tool was utilized. Of the
18 patients identified, only seven patients experienced complications during chemotherapy
treatment. A total of four patients had not yet completed treatment during the study;
however they did not experience any complications. Two patients, with stage III or IV
disease, were admitted to the hospital for supportive care after the first chemotherapy cycle.
A limitation to the quality improvement project was only 18 patients were enrolled for
telephone follow-up due to inadequate resources.
In a retrospective study conducted at the Cochin Hospital Department of Oncology
in France, chemotherapy-induced unscheduled hospitalizations rates were reviewed
(Coriat, 2012). The study was conducted in August 2008 and included all consecutive
patients receiving chemotherapy infusions with no exclusion criteria identified. A total of
259 outpatients were identified that received 2,374 cycles of chemotherapy.

A

standardized five-step procedure with the initial steps involving clinical evaluation,
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chemotherapy prescription, and preparation of chemotherapy prior to treatment was used
for hospital-home monitoring program. The last step of the hospital-home monitoring
program included the physician conducting follow-up with patient by calling him or her
twice, on the second and eighth days after chemotherapy, to collect data on treatment
toxicity and potentially adverse events and to provide patient with recommendations.
These could range from setting up an appointment with the physician to identifying
whether the patient needs hospitalization and continuing to educate the patient. It was
found that telephone follow-up was a cost-effective strategy for offering ambulatory
chemotherapy treatment to patients with cancer. Coriat found that there was a reduction in
the frequency of unexpected hospitalizations with the use of the hospital-home monitoring
program: 4.9% down to 2.4% with the program. The program allowed for patients to
address questions regarding medications and chemotherapy management while the
providing reinforcement of close physician follow-up.
Nurse-initiated telephone follow-up in both non-oncology and oncology
populations can have a positive impact on patient outcomes and quality of life. Specifically
in the oncology population, nurse-initiated telephone follow-up led to an improvement in
patient’s perception of care, symptom management, and unplanned hospitalizations.
Telephone follow-up was identified as cost effective method for follow-up in oncology
patients.
Next, the theoretical framework for this quality improvement project will be
presented.
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Theoretical Framework
Lewin’s Change Theory will be utilized to guide this quality improvement
project. The theory examines the process of planned change. Planned change is
described as occurring by design, as opposed to change that is spontaneous or that occurs
by happenstance or by accident. Making a change means trying to break a wellestablished custom or social habit (Lewin, 1951). According to Lewin there are three
phases that must occur if planned change is to be successful: unfreezing the status quo,
moving to a new state, and refreezing the change to make it permanent (McEwen, 2011).
Using this theory effective change can be implemented.
The concepts of field and force are central to Lewin’s theories on planned change.
Lewin states that change is a move from the status quo that results in disequilibrium
between opposing forces (Lewin, 1951). A field can be viewed as a system,
demonstrating when change occurs in one part of the system, the whole system must be
examined. Force is defined as a directed entity that has the characteristics of direction,
focus, and strength.
Driving forces and restraining forces are identified by Lewin as the two forces
involved in change. A driving force encourages or facilitates movement to a new
direction or goal, while a restraining force has the opposite effect. Driving forces
identified in this project include the support of administration, education session, and
literature supporting the importance of telephone follow-up post initial chemotherapy.
Restraining forces block or impede progress toward the goal. If driving forces and
restraining forces can be identified, it may be possible to predict if and when change
would be successful (Lewin, 1951). Some potential restraining forces identified for the
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project are reluctance of nurses to participate, adequate time to conduct telephone followup, and lack of patient/family participation when called.
During the unfreezing stage participants must be informed of the need for change
and should agree to change is needed. The educational session conducted with staff will
provide the opportunity to highlight the need for a change in practice and encourage staff
buy-in. The process of unfreezing involves finding a method of making it possible for
people to let go of an old pattern or habit that was counterproductive in some way
(Lewin, 1951). During the unfreezing process staff will be presented with the process for
telephone follow-up in the clinic and the template for documentation. Change in the
work environment can lead to feelings of uneasiness, uncertainty, and loss of control
(McEwen, 2011). Driving forces should exceed restraining forces during the second
phase, moving to a new state, of the planned change process. The refreezing phase is
when stabilization occurs and if successful change is assimilated into the system.
Permanency of new level, or permanency for a desired period, should be included in the
objective (Lewin, 1951). Permanency implies that the new force field is made relatively
secure against change. The pilot process will be viewed as moving to a new state of
practice and if implementation is agreed upon the protocol will be reviewed with all staff
as part of daily practice.
Next, study methods will be presented.
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Method
Purpose
The purpose of this quality improvement project was to develop a nurse telephone
follow-up procedure post initial chemotherapy.
Design
The project design included an educational activity and a post evaluation of the
telephone follow-up procedure.
Site and Sample
Target sample was fifteen biotherapy/chemotherapy certified nurses in the
Comprehensive Cancer Center at Rhode Island Hospital, an ambulatory clinic with an
infusion area consisting of 26 treatment chairs/stretchers.
Procedures
Brief background. Prior to the pilot period, nurses attempted to make post initial
chemotherapy follow-up calls as an expectation of their role; however there was not a
standardized process or tool for documentation of the follow-up call. Therefore calls
were not always being conducted, in part, due to lack of standardization and time. The
process was that follow-up calls were documented in a narrative progress note.
Assessments varied from nurse to nurse conducting the call. Patients and families were
instructed to call the clinic with any questions or concerns post initial chemotherapy
treatment. They were not informed that a nurse would contact them by phone in about 48
hours after treatment. Given lack of standardization and documentation of the process,
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nursing had not fully embraced telephone follow-up despite recognition of the need for
timely follow-up calls for oncology patients.
Previous to this project, the researcher developed a standardized documentation
tool in October of 2015 with assistance and approval from the leadership team at the
cancer center. The tool was created utilizing a standard assessment template for
conversion into a documentation tool in the EHR for the pilot period. The assessment tool
(Appendix A) was developed using common themes identified in research including
assessment of gastrointestinal issues (nausea, vomiting, constipation, and diarrhea),
activity level/fatigue, and risk for infection, medication review, and clinic follow-up. The
symptoms most experienced post chemotherapy were graded utilizing the Common
Terminology Criteria for Adverse Events (CTCAE) from the National Institutes of Health
and National Cancer Institute (2010). Grading of symptoms/adverse events refers to the
severity of the adverse event and the CTCAE displays grades 1 (minimal or no
symptoms) through grade 5 (severe symptoms) with unique clinical descriptions of
severity for each adverse event. The chemotherapy follow-up assessment documentation
tool was individualized and customized within the system to have patient specific
information automatically populate the documentation such as treatment plan and
attending physician. There was little research to suggest how long the follow-up call
would last, but based on the number of questions and allowing time for patient
discussion, it was estimated each call would require approximately 15 minutes.
The documentation tool was built into the EHR in August of 2016 by the
researcher with the assistance of the unit based Quality and Safety Manager. The student
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researcher conducted implementation of the standardized tool, nurse education and the
pilot in September of 2016.
Proposed change. This quality improvement project piloted a new standardized
tool and procedure for nurse-initiated telephone follow-up with patients post initial
chemotherapy treatment. A post initial chemotherapy follow-up script with assessment
tool for adverse events was piloted (Appendix A). The telephone assessment utilized the
researcher-developed, customized chemotherapy follow-up script with the documentation
template described previously. The nurse-initiated follow-up phone call script was added
for the purpose of this quality improvement project.
Procedures
Permission for the pilot was obtained from the Director of the Comprehensive
Cancer Center as well as the clinical manager for the Comprehensive Cancer Center at
Rhode Island Hospital. Prior to beginning the pilot, IRB determination of this proposal
as a quality improvement initiative was made by Lifespan IRB and Rhode Island College
IRB.
When a patient was in the clinic receiving their first chemotherapy treatment, the
nurse would notify the charge nurse of the first time patient. Typically, the nurse caring
for the patient on the first day of chemotherapy would remain the patient’s primary nurse
throughout their treatment course. At the time of the first chemotherapy treatment, the
patient was informed that a follow-up call would be made in about 48 hours. The patient
could designate a family member or friend to discuss their care with the nurse when the
call was conducted. The nurse would document the telephone encounter within the
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customized chemotherapy follow-up assessment screen in the notes section of the EHR.
The nurse would also document any indicated follow-up plans in the assessment screen.
After the documentation/assessment tool was developed and built within the
EHR, the participating nurses attended a one-hour education session. The purpose of the
education session was to review the researcher developed assessment tool and process for
utilization within the EHR. Importance of telephone follow-up and standardization of the
process were also explained during the session. Table 1 outlines the content of the
education session.
Table 1
Education Session Outline
Objectives

Content

Process For Conducting
Call and Documentation
-Call to be conducted
within 48 hours to all first
time chemotherapy patients

-Review development and
implementation of
standardized
documentation/assessment
tool

-Purpose of project

-Identify the driving force
for telephone follow-up
change

-Development of tool

-Documentation under
telephone encounter within
EHR with follow-up
(MD/NP/PA) initiated for
CTCAE score >3

-Identify process for
identification of
appropriate patients and
assignment of staff

-Review of current
literature

-Support of management

-Identify and demonstrate
competency in the
elements of assessment in

-Review of current process

-Utilization of charge nurse
to allow for time for call
backs
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the post initial
chemotherapy call
guidelines
-Discussion of potential
barriers

-Competency with
documentation of call
guidelines

The majority of the education session was dedicated to the background of the
quality improvement project to provide the nurses with an understanding of the
development of the tool along with the need for change. The importance of follow-up
with provider or LIP for any CTCAE score ≥3 or uncontrolled symptoms was also
stressed during the session. Provider follow-up or intervention was identified as
necessary for a CTCAE score ≥3 as there can be a negative impact on self-care ADLs and
on maintaining adequate nutritional status, leaving the patient at risk for poor symptom
management. Poor symptom management or uncontrolled symptoms in the past would
lead to ED visits or hospital admissions. Competency with call guideline and assessment
was demonstrated by having the nurse complete documentation on a test patient scenario
within the EHR test environment during the educational session. There was time at the
end of the educational session for participant questions or concerns.
Once all nurses completed the educational session, telephone follow-up calls were
piloted for one month in the Comprehensive Cancer Center at Rhode Island Hospital.
Nurses would identify all first time patients and assign a nurse to conduct the telephone
follow-up phone call. During the pilot period it was the responsibility of the charge nurse
to provide protected time for the staff nurse to conduct the telephone follow-up. Nurses
would attempt to contact the patients two times within 48 hours post initial
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chemotherapy. The expected number of patients who would receive first time
chemotherapy during the pilot was 15-20.
Nursing leadership and the Quality and Safety Manager for the clinic continued to
reinforce the value of follow-up calls post initial chemotherapy treatment during monthly
staff meetings and daily infusion room huddle.
Measurement
After the pilot period was complete, participating nurses attended a follow-up
session to complete a post evaluation of the chemotherapy follow-up guidelines script
(Appendix C). The evaluation looked at the ease of the tool, flow and appropriate
assessment of patients’ symptoms. A 5-point Likert scale was utilized on the post
evaluation assessment. The post evaluation completed by staff was reviewed for
validation of the chemotherapy follow-up assessment tool.
Next, results will be presented
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Results
Staff education was completed and was attended by all 15 staff nurses (100%).
The pilot period began on September 26, 2016 and ended on October 21, 2016. During
the four-week pilot period a total of 34 patients received first time chemotherapy.
Fourteen patients out of the 34 (41%) received a telephone follow-up call within fortyeight hours of receiving first time chemotherapy.
After the pilot period was completed, 10 nurses completed the post evaluation
survey (67%). Table 2 illustrates the results of the evaluation.
Table 2
Post Evaluation Results

6
5
4
3
2
1
0
Easy to Use

Flowed Logically

Strongly Disagree

Disagree

Assessment
questions
appropriate

Assessment
questions
elicited
appropriate
information

Neither Agree Nor Disagree

RN able to Took 30 minutes
document
or less
interventions

Agree

Strongly Agree

Review of the post evaluation results demonstrated that overall 70% of nurses
(n=7) responded strongly agree or agree for the ease of utilizing the script guideline.
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Twenty percent of the staff (n =2) selected neither agree nor disagree with comments that
included: “pain script difficult to complete”; “it would be more useful to have defined
targets versus defined script because the conversation is often facilitated by how the
patient responds to ‘how have you been feeling’”, and “difficult to access”.
The majority of the staff, 80% (n =8) agreed that the script flowed logically with
10% (n =1) disagreeing and 10% (n =1) neither agreed nor disagreed. Staff also felt
strongly that the assessment questions were appropriate to post chemotherapy patients,
with 80% validating the questions with strongly agree or agree. Ten percent of the staff
did not feel that the questions were appropriate and included the following comment: “the
time frame in which a patient gets called should be regimen specific”.
Staff felt strongly when questioned regarding the assessment questions eliciting
appropriate information from patient/family; 50% (n=5) strongly agreed, 40% (n=4)
agreed, and 10% (n=1) neither agreed nor disagreed. The staff also validated that there
was adequate room for documentation of interventions performed with 50% (n=5)
strongly agreed and 50% (n=5) agreed. Finally staff evaluated the time to conduct the
call and the completion of documentation with all staff agreeing the total time spent being
30 minutes or less; 50% (n=5) strongly agreed and 50% (n=5) agreed.
Additional comments on the post evaluation included: “The script would
automatically open at the bottom instead of the top of the page”, “Dedicated time to
complete calls would have been helpful” and “Patient demographics were not being
automatically pulled into the note template”.
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The student researchers in collaboration with other cancer center leadership, will
review all feedback and look at adjustments that can be made to further improve the
template.
Next, summary and conclusions will be discussed.
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Summary and Conclusions
Patients receiving chemotherapy in the outpatient clinic setting return home
immediately after completing treatment and do not have direct inpatient medical and
nursing supervision to monitor for and address side effects or adverse reactions of
treatment. The initiation of chemotherapy is an extremely anxiety provoking experience
for many patients and their families, whether inpatient or outpatient. Patients’ primary
concern is what to expect during and immediately following treatment. Patients are at an
increased risk of developing and experiencing symptoms while at home that require
medical care (emergency department or admission). As demonstrated in the literature
review, nurse-initiated telephone follow-up in both non-oncology and oncology
populations can have a positive impact on patient outcomes and quality of life.
Specifically in the oncology population, nurse-initiated telephone follow-up led to an
improvement in patient’s perception of care, symptom management and unplanned
hospitalizations.
Standardization of telephone follow-up after initial chemotherapy was identified
as a best practice standard to improve patient care and satisfaction as chemotherapy,
increasingly is delivered in the outpatient setting. Prior to this quality improvement
project, there was an expectation that the nurse would give the patient contact
information to call if needed and the conversation would be documented in a progress
note. There was not a standardized process or tool for documentation of follow-up post
initial chemotherapy with documentation that varied from nurse to nurse. A standardized
telephone follow-up tool with guidelines was developed utilizing current assessment

30

CTCAE criteria. The documentation/assessment tool was implemented and piloted for
one month with a post evaluation of the assessment tool.
Nurse education in the use of the on-line post initial chemotherapy assessment
script occurred at a monthly nursing meeting and was attended by 12 of the 15 nurses.
The remaining three nurses were educated two days later on the unit. Ten nurses out of a
potential 15 nurses in the project center (67%) completed the post evaluation
questionnaire at the end of the pilot month. Due to the project design and anonymity of
nurse response on the post evaluation questionnaire, it was not possible to determined
why the remaining five post evaluations were not completed.
Overall the template was well received by staff and utilized appropriately for
telephone follow-up. The feedback related to different chemotherapy regimens was
expected and will always be a challenge when looking to standardize a process in cancer
care. The script was not meant to be all inclusive of patients’ signs and symptoms;
however, it was designed to assess non-drug specific side effects experienced during
chemotherapy. There are numerous different chemotherapy regimens for each cancer
type and it would be challenging to individualize telephone follow-up specific to each
regimen. Nurse will need to use their specialized knowledge base of chemotherapy
protocols to tailor the use of the standard script when appropriate. The negative feedback
from staff was primarily related to the functionality and limitations of the EHR. The
template within the EHR had limitations such as opening automatically at the bottom of
the script which cannot be addressed except for educating to this fact in the future.
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Out of the 14 calls conducted, all were completed within the 48 hour time frame
with the patient or a family member. Anecdotally, patients and families responded
positively to the telephone follow-up process. Staff nurses participating in the pilot
commented to this writer that patients expressed appreciation for the nurse-initiated
contact even if they were not experiencing side effects at that time.
Limitations were also evident. Increased volume in the clinic over the course of
the pilot period posed a significant challenge in terms of protected time to complete the
calls. Due to computer limitations, the schedule was not able to be blocked for protected
time to conduct the follow-up. The responsibility of providing protected time away from
patient care to conduct the follow-up calls fell to the charge nurse. Scheduling
limitations of the EHR did not allow the nurse scheduled to be blocked in a formalized
way to allow for protected time to the conduct the follow-up call.

Also staff LOAs and

vacant positions in addition to the increased volume posed a challenge to the pilot. It was
predicted during the pilot period 15-20 patients would receive first time chemotherapy
and the actual number of first time chemotherapy patients was 34. Unfortunately, the
staff were not able to conduct calls to all first time patients during the pilot period and
may have accounted for only 10 post evaluation questionnaires being completed. The
staff were responsible for determining which team member would be conducting the call
based on scheduling and not every nurse was able to conduct a telephone follow-up
during the pilot period. Staffing engagement was also a limitation; given the increased
census, the staff was focused on the demands of increased patient volume and not
necessarily engaged in conducting the telephone follow-up.
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Future replication of this quality improvement project would require protected
time for staff to conduct the telephone follow-up. It must be determined how to block the
schedule within the EHR, or by other means, to allow for protected time. Protected time
to conduct the call would allow for an increase in the number of calls conducted and also
potentially increase staff engagement. Replication of the telephone follow-up could be
targeted to a specific disease group to allow for increased support for the nursing staff in
their efforts to conduct the calls and utilize the tool.
In conclusion, this project demonstrated positive feedback from staff nurses, with
70% or greater strongly agreeing or agreeing that the chemotherapy follow-up assessment
tool was easy to use and included appropriate of assessment questions.
Next, recommendations and implications for advanced nursing practice will be
discussed.
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Recommendations and Implications for Advanced Nursing Practice
This project validated the need for a standardized process and assessment tool for
nurse-initiated telephone follow-up after initial chemotherapy treatment in an outpatient
cancer center. Results demonstrated staff agreed that the standardized tool asked
appropriate questions and solicited appropriate answers from patients or family. The
advanced practice nurse (APRN), specifically the Clinical Nurse Specialist (CNS), is in
an exceptional position to identify, promote, and facilitate standardization of nurse-driven
programs.
In this quality improvement project, the APRN student had the opportunity to
develop a post initial chemotherapy telephone follow-up assessment tool and provide an
educational opportunity for staff members. The APRN student was able to work closely,
at an intradisciplinary level, with the nursing leadership of the cancer center and will
continue to be involved to update the telephone follow-up assessment tool and future
implementation in all cancer center sites. Prior to implementing the script at other sites,
staffing concerns must be addressed including protected time to conduct the follow-up
call. The leadership group will continue to refine the process in order to obtain the best
outcomes for both patients and staff while moving towards embracing the oncology
medical home care delivery model. The oncology medical home model is a patientfocused system of delivering quality cancer care that is efficient and coordinated.
Next steps include revising the assessment template based on feedback and
collaborating with the Quality and Safety Manager to determine a process for the tracking
of chemotherapy patients. Specifically, the percentage of first time patients that received
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telephone follow-up and the impact on emergency room visits and hospital admissions
over time should be assessed. Patient satisfaction will also be reviewed for the potential
positive impact of communication from the healthcare team, management of symptoms,
and explanation of care.
The APRN is a key member of any unit-based project with impact at the level of
the patient, nurse, and system as illustrated in this quality improvement project. The
ability of the APRN to be involved in all three spheres of nursing influence demonstrated
impact on patient care for the greater good including patient management and patient
satisfaction. The telephone follow-up assessment tool addressed the patient needs while
also providing patient education related to symptom management and early identification
of possible complications. Ultimately, if fully implemented, the standardized post initial
chemotherapy assessment could potentially have a positive impact on patient satisfaction
and provide an enhanced continuum of care in the outpatient setting. Impact on nursing
included nurse education and symptom management, with the ultimate goal of decreased
emergency room visits and avoidable hospitalizations. The tool facilitates the nurse to
promptly assess the patient for any complications and advocate on behalf of the patient
for appropriate follow-up care.
The APRN is in the position to influence patient care at the policy level as well.
Standardization of nurse-initiated telephone follow-up could lead to positive outcomes
and also best practice guidelines in cancer care. The APRN can collaborate with cancer
center leadership system wide to develop a standard of care procedure for telephone
follow-up post initial chemotherapy. It will be both essential and important for the
APRN to be a key stakeholder in the process of developing standardized policy/procedure
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related nurse-initiated telephone follow-up and also the maintenance of such
policy/procedure to determine the impact on delivery quality cancer care. Focusing on
the cancer center’s quality goals for 2017 including decreased emergency room
admissions, patients’ willingness to recommend, and pain management satisfaction will
aid in validation of the tool’s impact on providing quality cancer care and alignment with
the oncology medical home model.
A number of cited studies have demonstrated that nurse-initiated telephone
follow-up can have a positive impact on patient outcomes; however, further research is
needed. On a systems level, use of the tool and standardized process can be examined in
relation to emergency room visits and admissions to the inpatient unit. The overarching
goal for any cancer institution is to keep their patients out of the emergency room and
their care managed as well in the outpatient setting as is feasibly possible. There is a
need for further research examining the impact of telephone follow-up within the
oncology medical home model. Also, future research could include standardization and
validation of a tool to conduct telephone follow-up. Further research is required to
evaluate nurse-initiated follow-up calls, post initial chemotherapy as a best practice.
The APRN is a key stakeholder in promoting evidence-based practice and
bringing it into the daily practice of staff nurses to improve the quality of patient care
provided. Future goals of this project are to examine the impact of telephone follow-up
on patient satisfaction and outcomes, embodying the philosophy of the oncology medical
home. Research regarding the process of a standardized tool for telephone follow-up has
the potential to impact many and increase positive outcomes for chemotherapy patients.
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Appendix A
Comprehensive Cancer Center: Post Initial Chemotherapy Telephone Follow-Up Assessment
Comprehensive Cancer Center: Post Initial Chemotherapy Telephone Follow-Up
Script
Assessment/Narrative
Patient Active Problem List
Diagnosis
Treatment Plan:
Date First Chemotherapy:
Attending:

“How have you been feeling
since you received your
chemotherapy?”
Pain Pain assessment
Pain (activities that relieve):
Pain (aggravating factors):
Infection Fever
Chills
None
Constipation

Diarrhea

1

CTCAE V4 Grading
2
3
Persistent
Obstipation
symptoms
with manual
with regular evacuation
use of
indicted;
laxatives or limiting self
enemas;
care ADL
limiting
instrumental
ADL

Occasional
or
intermittent
symptoms;
occasional
use of stool
softeners,
laxatives,
dietary
modification
or enema
Increase
Increase of
of <4 stools 4-6 stools per
per day over day over
baseline,
baseline;
mild
moderate
increase in increase in
ostomy
ostomy output
output
compared to
baseline

Increase of
>=7 stools per
day over
baseline;
incontinence;
hospitalization
indicated;
severe increase
in ostomy

4
Lifethreatening
consequences;
urgent
intervention
indicated

Lifethreatening
consequences;
urgent
intervention
indicated
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compared to
baseline

Nausea

Vomiting

Fatigue

output
compared to
baseline;
limiting self
care ADL
Loss of
Oral intake
Inadequate
appetite
decreased
oral caloric or
without
without
fluid intake;
alteration in significant
tube feeding;
eating habits weight loss, TPN, or
dehydration or hospitalization
malnutrition indicated
1-2
3-5
>=6
episodes
episodes
episodes
(separated (separated by (separated by 5
by 5
5 minutes) in minutes) in 24
minutes) in 24 hrs
hrs; tube
24 hrs
feeding; TPN
or
hospitalization
indicated
Fatigue
Fatigue not
Fatigue not
relived by relieved by
relieved by
rest
rest; limiting rest; limiting
instrumental self care ADL
ADL

Lifethreatening
consequences;
urgent
intervention
indicated

Other:
Medications

Review current medications
Need for additional medications for symptom management
Prescription refills as appropriate

“How are you coping?”

Review Phone Triage/ Sick
line information (including
when appropriate to call)
Next appointment
Next appointment:
information: Are you able to
keep this appointment? If
not, can I help reschedule?
Referrals
MD
NP/PA

Comments/ Notes:

Navigator
RN

Social
Work

Infusion
RN

42
Time spent on call

Appendix B
Education Session Outline Telephone Follow-Up Post Initial Chemotherapy
Objectives:


Review development and implementation of standardization
documentation/assessment tool



Identify the driving force for telephone follow-up change



Identify process for identification of appropriate patients and assignment
of staff



Identify and demonstrate competency in the elements of assessment in the
post initial chemotherapy call guidelines

Background of quality improvement project


Purpose of project

Review of current process


Inconsistent telephone follow-up



Inconsistent documentation with no template

Review of current literature
Review of post initial chemotherapy follow-up guidelines
Process for conducting call and documentation


Call to be conducted within 48 hours to all first time chemotherapy
patients
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Documentation under telephone encounter within EHR with follow-up
(MD/NP/PA) initiated for CTCAE score >3



Support of management



Utilization of charge nurse to allow for time for call backs



Competency with documentation of call guidelines

Discussion of potential barriers
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Appendix C
Post Evaluation Chemotherapy Follow-Up Script Guidelines
Please circle the appropriate response in relation to your experience with the pilot of the
chemotherapy follow-up script guidelines.

1. The script guideline was easy to use

1. Strongly Disagree 2. Disagree 3. Neither agree nor disagree 4. Agree 5.
Strongly Agree

2. The script guideline flowed logically

1. Strongly Disagree 2. Disagree 3. Neither agree nor disagree 4. Agree 5.
Strongly Agree

3. Assessment questions were appropriate to post chemotherapy patients

1. Strongly Disagree 2. Disagree 3. Neither agree nor disagree 4. Agree
Strongly Agree

5.

4. Assessment questions elicited appropriate information from patient/family

1. Strongly Disagree 2. Disagree 3. Neither agree nor disagree 4. Agree 5.
Strongly Agree

5. Nurse was able to document interventions performed i.e. referral to LIP, sick
visit at clinic

1. Strongly Disagree 2. Disagree 3. Neither agree nor disagree 4. Agree 5.
Strongly Agree
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6. Conducting call and completion of documentation took 30 minutes or less

1. Strongly Disagree 2. Disagree 3. Neither agree nor disagree 4. Agree 5.
Strongly Agree

Additional Comments:

